Limited information on severe side effects from certain drugs is complicating efforts to assess their safety risks, including potential complications like vision loss or pancreatic damage. Researchers and legal experts face challenges in determining how frequently such serious adverse reactions may occur due to insufficient reported cases. The lack of comprehensive data raises concerns about public health oversight and accountability. Without clearer evidence, patients and regulators struggle to make informed decisions about usage.
Scant data about serious adverse effects makes it harder to answer scientific and legal questions about how often the drugs might cause serious harm like blindness or pancreatitis.
